Yunfeng Zhou

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Topics

Liver Metastases

Binding Protein

Top Venues

Cancer management and research

Drug design, development and therapy

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Haibin Ou, Lili Wang, Ziyao Xi, Hui Shen, Yaofei Jiang, Yingying Shi, Yu Liu, Yunfeng Zhou
MYO10 contributes to the malignant phenotypes of colorectal cancer via RACK1 by activating integrin/Src/FAK signaling. Cancer science 113 (11) (2022)
Long Long, Li Zhang, Yuhan Yang, Yunfeng Zhou, Honglei Chen
Different clinical significance of novel B7 family checkpoints VISTA and HHLA2 in human lung adenocarcinoma. Immunotherapy 14 (6) (2022)
Zhewen Zheng, Xue Zhang, Jian Bai, Long Long, Di Liu, Yunfeng Zhou
PGM1 suppresses colorectal cancer cell migration and invasion by regulating the PI3K/AKT pathway. Cancer cell international 22 (1) (2022)
Ningning Yang, Lu Xu, Qingqing Wang, Fengxia Chen, Yunfeng Zhou
Construction and validation of a prognostic nomogram for anal squamous cell carcinoma. Cancer medicine (2021)
Hui Yang, Shaoxing Sun, Zijie Mei, Qingming Xiang, Chunxu Yang, Min Chen, Conghua Xie, Yunfeng Zhou, Hui Qiu
A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent Cervical Cancer After Failure of First-Line Therapy. Drug design, development and therapy 15 (2021)
Yu Qian, Yuan Wu, Zilong Yuan, Xiaohui Niu, Yaoyao He, Jun Peng, Yingying Shi, Shaozhong Wei, Desheng Hu, Yunfeng Zhou
The Frequency of Circulating Tumour Cells and the Correlation with the Clinical Response to Standard Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: A Prospective Study. Cancer management and research 11 (2019)